14-3-3:Shc Scaffolds Integrate Phosphoserine and Phosphotyrosine Signaling to Regulate Phosphatidylinositol 3-Kinase Activation and Cell Survival
Barry, Emma F., Felquer, Fernando A., Powell, Jason A., Biggs, Lisa, Stomski, Frank C., Urbani, Andrea, Ramshaw, Hayley, Hoffmann, Peter, Wilce, Matthew C., Grimbaldeston, Michele A., Lopez, Angel F., Guthridge, Mark A.
Published in The Journal of biological chemistry (01.05.2009)
Published in The Journal of biological chemistry (01.05.2009)
Get full text
Journal Article
Growth factor pleiotropy is controlled by a receptor Tyr/Ser motif that acts as a binary switch
Guthridge, Mark A, Powell, Jason A, Barry, Emma F, Stomski, Frank C, McClure, Barbara J, Ramshaw, Hayley, Felquer, Fernando A, Dottore, Mara, Thomas, Daniel T, To, Bik, Begley, C Glenn, Lopez, Angel F
Published in The EMBO journal (08.02.2006)
Published in The EMBO journal (08.02.2006)
Get full text
Journal Article
The phosphoserine-585–dependent pathway of the GM-CSF/IL-3/IL-5 receptors mediates hematopoietic cell survival through activation of NF-κB and induction of bcl-2
Guthridge, Mark A., Barry, Emma F., Felquer, Fernando A., McClure, Barbara J., Stomski, Frank C., Ramshaw, Hayley, Lopez, Angel F.
Published in Blood (01.02.2004)
Published in Blood (01.02.2004)
Get full text
Journal Article
14-3-3:Shc Scaffolds Integrate Phosphoserine and Phosphotyrosine Signaling to Regulate Phosphatidylinositol 3-Kinase Activation and Cell SurvivalS
Barry, Emma F., Felquer, Fernando A., Powell, Jason A., Biggs, Lisa, Stomski, Frank C., Urbani, Andrea, Ramshaw, Hayley, Hoffmann, Peter, Wilce, Matthew C., Grimbaldeston, Michele A., Lopez, Angel F., Guthridge, Mark A.
Published in The Journal of biological chemistry (01.05.2009)
Published in The Journal of biological chemistry (01.05.2009)
Get full text
Journal Article
The phosphoserine-585-dependent pathway of the GM-CSF/IL-3/IL-5 receptors mediates hematopoietic cell survival through activation of NF-kappaB and induction of bcl-2
Guthridge, Mark A, Barry, Emma F, Felquer, Fernando A, McClure, Barbara J, Stomski, Frank C, Ramshaw, Hayley, Lopez, Angel F
Published in Blood (01.02.2004)
Get full text
Published in Blood (01.02.2004)
Journal Article
A PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING TRYPSINOGEN AND CHYMOTRYPSINOGEN
TOSH, DAVID, BRANDT, RALF, FELQUER, FERNANDO, KENYON, JULIAN, NORMAN, CLAYTON, PAUL, RODNEY
Year of Publication 26.10.2018
Get full text
Year of Publication 26.10.2018
Patent
Pharmaceutical composition for treating cancer comprising trypsinogen and chymotrypsinogen
TOSH DAVID, CLAYTON PAUL RODNEY, FELQUER FERNANDO, BRANDT RALF, KENYON JULIAN NORMAN
Year of Publication 26.01.2018
Get full text
Year of Publication 26.01.2018
Patent
A pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent
TOSH DAVID, CLAYTON PAUL RODNEY, FELQUER FERNANDO, BRANDT RALF, KENYON JULIAN NORMAN
Year of Publication 15.08.2012
Get full text
Year of Publication 15.08.2012
Patent